Prostate Cancer
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey.
December 31, 2024
Cardiovascular risks of Asian patients on androgen-receptor-targeted agents for prostate cancer: a systematic review and meta-analysis.
December 31, 2024
Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) During Radical Prostatectomy: A Systematic Review and Meta-analysis.
December 30, 2024
How many cores should be collected per region of interest in fusion targeted prostate biopsy? A retrospective single institution statistical simulation.
December 30, 2024
The Impact of Cancer Status on Anxiety in Prostate Cancer Patients: A Network Analysis.
December 30, 2024
Accelerated growth and local progression of radiorecurrent prostate cancer in an orthotopic bioluminescent mouse model.
December 30, 2024
Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer.
December 30, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer.
December 30, 2024
Prostate Brachytherapy With Cs-131: Long-term Results Compared With Published Stereotactic Body Radiotherapy Data.
December 27, 2024
Total Prostate-Specific Antigen (PSA) Testing in Capillary Samples: Proof-of-Principle and Feasibility Study for Home Self-Testing for Prostate Cancer.
December 27, 2024
Automatic MRI-TRUS Fusion Technique for Transperineal Biopsy Guidance: From Preoperative Planning to Intraoperative Navigation.
December 27, 2024
Prostate cancer burden in South Asia: A systematic analysis of global burden of disease data (1990-2021).
December 27, 2024
Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life.
December 26, 2024
Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapy.
December 26, 2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI.
December 26, 2024